Akriderm GK - a drug for external use, anti-inflammatory, antibacterial and antifungal action.
Release form and composition
The drug is made in two dosage forms:
- Cream Akriderm GK white or almost white in color, with a content of 1 g of 640 mcg betamethasone dipropionate, 1 mg of gentamicin sulfate, 10 mg of clotrimazole. In tubes of 15 or 30 g;
- Ointment Akriderm GK white or almost white in color, with the content in 1 g of 640 mcg betamethasone dipropionate, 1 mg of gentamicin sulfate, 10 mg of clotrimazole. In tubes of 15 or 30 g;
Indications for use Akriderma GK
According to the instructions, Akriderm GC is shown when:
- Limited neurodermatitis (including simple chronic lichen);
- Diffuse neurodermatitis (including atopic dermatitis);
- Allergic or simple dermatitis (especially complicated by secondary infections);
- Ringworm (candida, dermatophytes, multi-colored lichen), especially localized in large folds of the skin and inguinal region.
According to the instructions, Akriderm GK is prohibited to apply in the following cases:
- Skin signs of syphilis;
- Open wounds;
- Skin reactions after vaccination;
- Herpes simplex;
- Perforation of the eardrum (in the treatment of external otitis media);
- Hypersensitivity to one or more components of the drug.
During pregnancy, the appointment of Acryderma GC is allowed, but only in cases where the intended benefit to the woman outweighs the potential danger to the fetus. The use of medication in the first trimester of pregnancy should be as short as possible and limited to small areas of skin.
When breastfeeding, use Akriderm GK is not recommended, as it is not known for certain whether its components are excreted in breast milk.
Ointment Akriderm GK is not prescribed to children under the age of 2 years, and the cream - children under the age of 1 year. With caution, the drug in any dosage form is prescribed to children aged 2-18 years.
Since in children the area of the skin in relation to body weight is larger than in adult patients, external use of the drug is fraught with an increased risk of adverse reactions, as well as atrophic changes in the skin. Therefore, the use of Akriderma GK in children aged 2-18 years should be of minimal duration.
Dosing and Administration Akriderma GK
Akriderm GK cream is applied to the affected areas of the body with a small layer twice a day (morning and evening). In mild cases of disease, it is recommended to use the medicine once a day. The duration of therapy, as a rule, does not exceed 0.5-1 month and depends on the severity of the disease and the effectiveness of therapy.
Ointment Akriderm GK is applied with a thin layer to the affected skin, gently rubbing twice a day. The duration of therapy is individual, but, as a rule, does not exceed 0.5-1 month.
If for several days after the start of treatment with Akriderm GK there is no improvement, you should either change the treatment regimen or undergo additional examination to clarify the diagnosis.
Side effects Akriderma GK
According to the instructions, Akriderm GK can cause the following side effects:
- Local: burning sensation, itching, dry skin, irritation, hypertrichosis, folliculitis, hypopigmentation, steroid acne, allergic reactions. When using occlusive dressings, infection, prickly heat, stretch marks, maceration, skin atrophy are possible;
- Systemic: when applied to large areas of the body and with long-term treatment, an increase in body weight, increased blood pressure, osteoporosis, agitation, exacerbation of hidden foci of infection, expression of the gastrointestinal mucosa, insomnia, hyperglycemia, edema, dysmenorrhea are possible.
When using the drug in children, such adverse reactions are possible as reversible inhibition of the function of the adrenal cortex, glucosuria, manifestation of Cushing's syndrome (due to the action of betamethasone), ototoxic and nephrotoxic action (due to the action of gentamicin).
With prolonged use of the drug in high dosages may develop hypercorticism (reversible inhibition of the adrenal cortex, glycosuria, hyperglycemia, manifestations of Cushing's syndrome).
When these symptoms appear, the drug should be gradually discontinued, symptomatic treatment should be carried out and, if necessary, electrolyte disturbances should be corrected.
Akriderm GK is not intended for use in ophthalmology, so avoid ingestion of the drug in the eyes and on other mucous membranes.
In the event of symptoms caused by hypersensitivity reactions to components of Acryderm HA, such as skin irritation, the emergence of a resistant bacterial or fungal microflora, the drug is recommended to cancel and prescribe an alternative treatment.
When using the drug for a long period of time over large areas of the skin, using occlusive dressings, as well as when using the drug in children, atrophic changes are not excluded.
If according to the instructions Akriderm GK prescribed for a long period of time, you can not abruptly stop treatment. It is recommended to gradually discontinue the drug.
Analogs Akriderma GK
Structural analogues of Akriderm GK are Sanoderm and Triacutan drugs.
Terms and conditions of storage
Akriderm GK should be stored in a dark, dry and out of reach of children. The shelf life of the ointment and cream is two years.